Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oncolysin B immunoconjugate of mouse anti-CD19 antibody linked to ricin data

Ten of the 12 patients in a Phase I/II trial remain

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE